continu infus weekli cisplatin pancreat carcinoma mid-atlant oncolog program studi fifty-six patient biopsy-proven metastat measur adenocarcinoma pancrea combin protract intraven infus low dose weekli bolu cisplatin week rest period object respons rate patient complet respons confid interv median surviv time treat patient month patient aliv year median surviv time proport aliv year prior report larg patient group due patient select 